Title : Tumor-Targeted Nanoparticles Deliver a Vitamin D-Based Drug Payload for the Treatment of EGFR Tyrosine Kinase Inhibitor-Resistant Lung Cancer.

Pub. Date : 2018 Aug 6

PMID : 29902012






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tumor-Targeted Nanoparticles Deliver a Vitamin D-Based Drug Payload for the Treatment of EGFR Tyrosine Kinase Inhibitor-Resistant Lung Cancer. Vitamin D epidermal growth factor receptor Homo sapiens
2 Our results demonstrated that the delivery of vitamin D-based drug payloads via tumor-targeted EGFR-LP has promise as a new therapy for EFGR TKI resistant lung cancer. Vitamin D epidermal growth factor receptor Homo sapiens